SCHEMBL7213174

SCHEMBL7213174

Cc1c(Cl)cccc1S(=O)(=O)Nc1ccc(Br)cc1C(=O)Nc1ccc(Br)cc1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC10A6 Q3KNW5 2/20 0.61
SLC10A2 Q12908 1/20 0.61
SLC10A1 Q14973 1/20 0.61
GPR27 Q9NS67 3/20 0.46
TP53 P04637 1/20 0.46
MAPT P10636 1/20 0.46
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
IDH1 O75874 3/20 0.45
MT-CO2 P00403 1/20 0.44
METAP2 P50579 3/20 0.44
SLC40A1 Q9NP59 1/20 0.43
EDNRB P24530 1/20 0.43
EDNRA P25101 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
SLC6A3 Q01959 1/20 0.43
ENPP2 Q13822 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7213146 0.90 MT-CO2 (0.55) SLC10A6SLC10A2SLC10A1GPR27TP53
SCHEMBL7128140 0.87 SLC10A6 (0.61) SLC10A6SLC10A2SLC10A1GPR27TP53
SCHEMBL27575233 0.85 SLC10A6 (0.58) SLC10A6SLC10A2SLC10A1GPR27TP53
SCHEMBL7128469 0.84 SLC10A2 (0.60) SLC10A6SLC10A2SLC10A1GPR27TP53
SCHEMBL7124358 0.81 SLC10A6 (0.59) SLC10A6SLC10A2SLC10A1GPR27MEN1
SCHEMBL7117455 0.80 SLC10A2 (0.60) SLC10A6SLC10A2SLC10A1GPR27TP53
SCHEMBL7208733 0.79 SLC10A6 (0.71) SLC10A6SLC10A2SLC10A1GPR27TP53
SCHEMBL7209360 0.78 EDNRA (0.65) SLC10A6SLC10A2SLC10A1EDNRA
SCHEMBL7116008 0.78 SLC10A6 (0.85) SLC10A6SLC10A2SLC10A1GPR27MAPT
SCHEMBL7126120 0.78 SLC10A6 (0.98) SLC10A6SLC10A2SLC10A1GPR27MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1187531-A4 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2003-05-28 EP claimed
US-6458845-B1 METHOD OF ANTAGONIZING A MACROPHAGE SCAVENGER RECEPTOR COMPRISING ADMINISTERING TO A SUBJECT IN NEED OF TREATMENT AN EFFECTIVE AMOUNT OF AN N-PHENYL-2-(3-TRIFLUOROMETHYLPHENYLSULFONAMIDO)BENZAMIDE, A SMITHKLINE BEECHAM CORPORATION 2002-10-01 US claimed
EP-1187531-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SmithKline Beecham Corporation (US) 2002-03-20 EP claimed
WO-2001098264-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-27 WO claimed
WO-2000078145-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2000-12-28 WO claimed
US-6458845-B1 METHOD OF ANTAGONIZING A MACROPHAGE SCAVENGER RECEPTOR COMPRISING ADMINISTERING TO A SUBJECT IN NEED OF TREATMENT AN EFFECTIVE AMOUNT OF AN N-PHENYL-2-(3-TRIFLUOROMETHYLPHENYLSULFONAMIDO)BENZAMIDE, A SMITHKLINE BEECHAM CORPORATION 2002-10-01 US disclosed
WO-2001098264-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-27 WO disclosed